Australia markets closed

AusCann Group Holdings Ltd (AC8.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.04000.0000 (0.00%)
At close: 05:10PM AEDT

AusCann Group Holdings Ltd

35 Havelock Street
Level 4
West Perth, WA 6005
Australia
61 8 9426 8999
https://auscann.com.au

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Christopher Mews A.C.I.S., ACIS, B. Bus, C.P.A., CPACFO & Director50kN/AN/A
Mr. Layton Patrick MillsExec. Officer302.5kN/AN/A
Dr. Margaret CurtisHead of R&D241.58kN/AN/A
Ms. Susan Patricia Park A.C.A., A.C.I.S., ACA, ACIS, ACSA, AGIA, B.Com., BCompany Sec.N/AN/A1975
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.

Corporate governance

AusCann Group Holdings Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.